Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 15, 2024, after the close
10-K filed Feb 28, 2024, 59 days after period end · 0001299130-24-000054
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $58.36M | $27.35M | $36.02M | $25.13M |
| Net Income | -$82.02M |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$84.38M |
| -$69.33M |
| $74.94M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
